EPS Creative Health Technology Group Limited (HKG:3860)
Hong Kong · Delayed Price · Currency is HKD 0.5900
+0.0300 (5.36%)
Jul 31, 2026, 3:46 PM HKT
HKG:3860 Ratios and Metrics
Market cap in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 308 | 287 | 258 | 505 | 555 | 700 | |
Market Cap Growth | 24.21% | 11.11% | -48.82% | -9.01% | -20.71% | 47.37% |
Enterprise Value | 245 | 252 | 287 | 420 | 389 | 518 |
Last Close Price | 0.59 | 0.55 | 0.49 | 0.99 | 1.09 | 1.37 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | 6.70 | - | - | - |
PS Ratio | 0.67 | 0.63 | 0.48 | 0.78 | 1.23 | 1.35 |
PB Ratio | 2.02 | 1.88 | 1.59 | 3.66 | 6.06 | 5.01 |
P/TBV Ratio | 19.05 | 17.76 | 9.95 | - | 6.33 | 5.33 |
P/FCF Ratio | 12.27 | 11.44 | - | - | - | 187.22 |
P/OCF Ratio | 10.92 | 10.18 | - | - | - | 174.04 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.54 | 0.55 | 0.53 | 0.65 | 0.86 | 1.00 |
EV/EBITDA Ratio | 12.48 | 15.21 | 34.19 | - | - | - |
EV/EBIT Ratio | 88.26 | 90.81 | - | - | - | - |
EV/FCF Ratio | 9.75 | 10.03 | - | - | - | 138.67 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.19 | 0.19 | 0.13 | 0.98 | 0.80 | 0.07 |
Debt / EBITDA Ratio | 1.47 | 1.47 | 1.89 | - | - | - |
Debt / FCF Ratio | 1.15 | 1.15 | - | - | - | 2.44 |
Net Debt / Equity Ratio | -0.72 | -0.72 | -0.78 | 0.03 | -0.77 | -1.42 |
Net Debt / EBITDA Ratio | -6.64 | -6.64 | -15.01 | -0.24 | 1.73 | 16.74 |
Net Debt / FCF Ratio | -4.38 | -4.38 | 5.34 | -0.12 | 1.75 | -53.22 |
Asset Turnover | 1.41 | 1.41 | 1.42 | 1.96 | 1.73 | 2.32 |
Inventory Turnover | 17.38 | 17.38 | 27.78 | 33.44 | 20.97 | 34.34 |
Quick Ratio | 1.51 | 1.51 | 2.26 | 0.88 | 1.62 | 3.22 |
Current Ratio | 1.83 | 1.83 | 2.89 | 1.03 | 1.88 | 3.46 |
Return on Equity (ROE) | -7.00% | -7.00% | 20.21% | -23.06% | -43.44% | -19.25% |
Return on Assets (ROA) | 0.53% | 0.53% | -0.72% | -5.21% | -10.13% | -3.63% |
Return on Invested Capital (ROIC) | 6.49% | 7.02% | -4.52% | -33.58% | - | - |
Return on Capital Employed (ROCE) | 1.40% | 1.40% | -1.70% | -12.20% | -37.80% | -6.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -4.50% | -4.82% | 14.93% | -4.37% | -8.24% | -3.23% |
FCF Yield | 8.15% | 8.74% | -9.14% | -6.65% | -7.30% | 0.53% |
Dividend Yield | 1.70% | - | 2.06% | - | - | - |
Buyback Yield / Dilution | -0.24% | -0.24% | -4.18% | - | - | - |
Total Shareholder Return | 1.45% | -0.24% | -2.12% | - | - | - |